Redefining Readiness: How Remote Pharmacy Monitoring Strengthens Compliance and Streamlines Clinical Trial Operations

Explore how leading IDS pharmacies are improving accuracy, reducing site burden, and accelerating trial timelines through remote monitoring workflows and digital accountability systems.

Overview

Monitoring visits are essential to maintaining compliance, ensuring accurate drug accountability, and safeguarding investigational product integrity across clinical trials. Yet traditional, fully on-site reviews place a heavy burden on IDS teams, demanding extensive coordination, manual documentation, and hours of physical verification.

As clinical trials grow more complex and remote-first operations become the norm, research pharmacies need modern tools and digital oversight models that maintain audit readiness without overwhelming staff or delaying trial progress.

This white paper explores the shift toward remote and hybrid monitoring models and outlines how IDS teams can adopt digital-first practices to optimize workflows, enhance data accuracy, and reduce operational strain.

This White Paper Covers:
Why Remote Monitoring Matters for IDS Pharmacies

With nearly 72% of monitor visits now completed remotely, leading research sites are leveraging digital documentation, remote access tools, and structured workflows to:

In the white paper, learn how you can improve trial quality while protecting staff time
and resources.

Download the Full White Paper

Download our white paper to learn how IDS teams are cutting costs, improving compliance, and staying audit-ready.